Vanguard Group Inc. Has $304.22 Million Stock Position in Innospec Inc. $IOSP

Vanguard Group Inc. lifted its holdings in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 0.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,210,768 shares of the specialty chemicals company's stock after purchasing an additional 30,031 shares during the period. Vanguard Group Inc. owned 12.78% of Innospec worth $304,220,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Westwood Holdings Group Inc. boosted its position in shares of Innospec by 28.3% during the 1st quarter. Westwood Holdings Group Inc. now owns 382,410 shares of the specialty chemicals company's stock valued at $36,233,000 after purchasing an additional 84,314 shares in the last quarter. R Squared Ltd bought a new stake in shares of Innospec during the 1st quarter valued at about $262,000. US Bancorp DE boosted its position in shares of Innospec by 4.2% during the 1st quarter. US Bancorp DE now owns 5,082 shares of the specialty chemicals company's stock valued at $482,000 after purchasing an additional 207 shares in the last quarter. XTX Topco Ltd bought a new stake in shares of Innospec during the 1st quarter valued at about $1,189,000. Finally, Mackenzie Financial Corp boosted its position in shares of Innospec by 19.5% during the 1st quarter. Mackenzie Financial Corp now owns 3,559 shares of the specialty chemicals company's stock valued at $337,000 after purchasing an additional 580 shares in the last quarter. Institutional investors own 96.64% of the company's stock.

Innospec Trading Up 3.7%

IOSP stock traded up $3.13 during trading on Friday, reaching $87.12. 144,472 shares of the stock were exchanged, compared to its average volume of 204,553. The firm's 50 day moving average is $84.07 and its 200 day moving average is $90.56. Innospec Inc. has a twelve month low of $74.10 and a twelve month high of $128.35. The firm has a market cap of $2.16 billion, a P/E ratio of 111.69 and a beta of 1.07.

Innospec (NASDAQ:IOSP - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.09. Innospec had a return on equity of 10.89% and a net margin of 1.08%.The business had revenue of $439.70 million for the quarter, compared to the consensus estimate of $440.70 million. During the same period in the prior year, the business earned $1.39 EPS. The firm's revenue for the quarter was up 1.1% on a year-over-year basis. As a group, analysts predict that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen lowered Innospec from a "buy" rating to a "hold" rating in a research report on Tuesday, May 6th. One investment analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat, the stock presently has a consensus rating of "Strong Buy".

Innospec Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.